136 related articles for article (PubMed ID: 2294065)
1. MSN-1 antibody in the evaluation of female genital tract adenocarcinomas.
Poropatich C; Nozawa S; Rojas M; Chapman WB; Silverberg SG
Int J Gynecol Pathol; 1990; 9(1):73-9. PubMed ID: 2294065
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
4. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
5. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
6. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
7. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
8. [The production and reactivity of the monoclonal antibody (MCA-97) to endometrial adenocarcinoma].
Inoue M; Saito J; Abe Y; Tanaka Y; Ueda G; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):53-8. PubMed ID: 3950463
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of difference between cervical and endometrial adenocarcinomas of the uterus--using monoclonal antibodies of CEA and cytokeratin.
Jinnouchi H
Fukushima J Med Sci; 1987 Jun; 33(1):29-46. PubMed ID: 2459040
[No Abstract] [Full Text] [Related]
10. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
[TBL] [Abstract][Full Text] [Related]
12. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
13. A nonsialylated high-molecular-weight glycoprotein defined by a monoclonal antibody to adenocarcinoma of the uterine endometrium.
Inoue M; Sasagawa T; Shimizu C; Shimizu H; Saito J; Ueda G; Tanizawa O
Gynecol Oncol; 1989 Jun; 33(3):344-50. PubMed ID: 2656426
[TBL] [Abstract][Full Text] [Related]
14. The immunohistochemical discrimination of endometrioid adenocarcinomas.
Dabbs DJ; Sturtz K; Zaino RJ
Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of HNK-1-defined antigen in gynecologic tumors with argyrophilia.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Inoue Y; Abe Y; Tanizawa O
Int J Gynecol Pathol; 1986; 5(2):143-50. PubMed ID: 2424852
[TBL] [Abstract][Full Text] [Related]
16. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of carcinoembryonic antigen in adenocarcinoma of the endocervix and the endometrium.
Toki T; Oikawa N; Tase T; Wada Y; Yajima A; Suzuki M
Tohoku J Exp Med; 1985 May; 146(1):27-32. PubMed ID: 3895576
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma.
McCluggage WG; Maxwell P; Veenstra H; Fick CE; Laeng RH; Tiltman AJ
Histopathology; 2001 Jun; 38(6):542-9. PubMed ID: 11422498
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in gynecologic tumors.
Ueda G; Shimizu C; Tanaka Y; Inoue M; Tanizawa O; Ogawa M; Mori T
Gynecol Oncol; 1989 Jan; 32(1):37-40. PubMed ID: 2462532
[TBL] [Abstract][Full Text] [Related]
20. The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas.
Maes G; Fleuren GJ; Bara J; Nap M
Int J Gynecol Pathol; 1988; 7(2):112-22. PubMed ID: 3294194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]